Financial Counselors Inc Novo Nordisk A S Transaction History

Financial Counselors Inc

$6.5 Billion
Q1 2025

A detailed history of Financial Counselors Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Financial Counselors Inc holds 9,755 shares of NVO stock, worth $656,999. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,755

Previous 10,290 5.2%

Holding current value

$656,999

Previous $885,000 23.5%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	SELL	$69.3 - $90.95 $37,075 - $48,658	-535 Reduced 5.2%	9,755 $677,000
Q4 2024 Feb 11, 2025	SELL	$85.0 - $120.04 $61,115 - $86,308	-719 Reduced 6.53%	10,290 $885,000
Q3 2024 Nov 13, 2024	BUY	$119.07 - $145.42 $13,693 - $16,723	115 Added 1.06%	11,009 $1.31 Million
Q2 2024 Aug 01, 2024	SELL	$122.71 - $146.91 $175,229 - $209,787	-1,428 Reduced 11.59%	10,894 $1.56 Million
Q1 2024 May 02, 2024	BUY	$102.11 - $135.92 $71,477 - $95,143	700 Added 6.02%	12,322 $1.58 Million
Q4 2023 Jan 26, 2024	BUY	$87.78 - $105.45 $4,827 - $5,799	55 Added 0.48%	11,622 $1.2 Million
Q3 2023 Nov 07, 2023	BUY	$90.94 - $199.54 $622,120 - $1.37 Million	6,841 Added 144.75%	11,567 $1.05 Million
Q2 2023 Jul 27, 2023	BUY	$155.98 - $172.65 $4,211 - $4,661	27 Added 0.57%	4,726 $765,000
Q1 2023 May 02, 2023	BUY	$132.34 - $159.14 $31,761 - $38,193	240 Added 5.38%	4,699 $748,000
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $25,534 - $33,697	-249 Reduced 5.29%	4,459 $603,000
Q2 2022 Aug 02, 2022	BUY	$103.24 - $121.81 $69,687 - $82,221	675 Added 16.74%	4,708 $525,000
Q1 2022 Apr 28, 2022	BUY	$93.1 - $112.54 $35,936 - $43,440	386 Added 10.58%	4,033 $448,000
Q4 2021 Feb 10, 2022	SELL	$95.88 - $117.08 $75,745 - $92,493	-790 Reduced 17.8%	3,647 $408,000
Q2 2021 Aug 03, 2021	SELL	$67.66 - $84.76 $204,130 - $255,720	-3,017 Reduced 40.47%	4,437 $372,000
Q1 2021 Apr 29, 2021	BUY	$67.06 - $75.82 $499,865 - $565,162	7,454 New	7,454 $503,000
Q4 2019 Jan 31, 2020	SELL	$49.86 - $58.26 $240,524 - $281,046	-4,824 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$47.54 - $53.43 $4,754 - $5,343	-100 Reduced 2.03%	4,824 $249,000
Q1 2019 May 10, 2019	BUY	$46.36 - $52.63 $228,276 - $259,150	4,924 New	4,924 $258,000

Others Institutions Holding NVO

# of Institutions

1,768

Shares Held

330M

Call Options Held

11.3M

Put Options Held

15.5M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $152B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Counselors Inc with notifications on news.

Account

Financial Counselors Inc Novo Nordisk A S Transaction History